Rottenstein Law Group Supports AARP Advisory about Coffee Interference with Medications, Including Fosamax
(New York, NY, December 19, 2011) The Rottenstein Law Group, which represents clients with claims stemming from the severe side effects of the osteoporosis drug Fosamax, is supporting the warning given by the AARP that coffee might block the absorption or intensify the effects of some medications, including Fosamax.
According to a blog entry posted to the AARP’s Web site on December 5, “the coffee you drink in the morning with some of your prescription drugs can either block their absorption or increase their effects.” The AARP piece references an article that ran in late November in the Health section of the New York Times.
“With some of these drugs,” wrote AARP health and nutrition writer Cindy Sagon, “the interaction is caused by caffeine; with others, its coffee’s other compounds that seem to be having an effect. Studies show that drugs like antidepressants, thyroid medication and osteoporosis drugs can be affected by coffee.
A study found that taking the osteoporosis drug alendronate (brand name, Fosamax) with black coffee or orange juice reduced its absorption by about 60 percent. The drug needs to be taken with water on an empty stomach at least 30 minutes before breakfast for optimum effect.”
Fosamax itself is not without issues. Despite being the most popular osteoporosis treatment on the market, it has been linked to several serious side effects. In 2004, researchers found a causal connection between Fosamax and osteonecrosis of the jaw, a condition that causes the jawbone to literally die because of a lack of blood supply. More recently, there has been a link between Fosamax and low-impact femur fractures experienced from standing height or less. Evidence is mounting that Fosamax and similar drugs prescribed to treat osteoporosis cause a dramatic increase in the risk of this kind of rare fracture to the thigh bone.
As of June 30, 2011, according to Merck, the manufacturer of Fosamax, approximately 1,650 cases, which consist of approximately 2,050 plaintiff groups, had been filed and were pending against the company in both state and federal courts.
The Rottenstein Law Group advises anyone with a friend or family member who has been prescribed Fosamax or another osteoporosis drug to recommend to that person that he or she consult a physician immediately, then speak to a qualified Fosamax lawyer. The Rottenstein Law Group lawyers have a total of more than 25 years of experience fighting for the rights of clients who have suffered harm due to the negligence of powerful corporations. Affected individuals are advised to keep apprised of the latest news concerning the Fosamax femur fracture lawsuits by checking the Fosamax Femur Fracture Lawsuit Information Center for updated information. The site is equipped with easy-to-use social media features which will enable users to spread the word about the dangers of Fosamax.
About the Rottenstein Law Group
The Rottenstein Law Group is a New York-based law firm that represents clients in mass tort actions. The firm was founded by Rochelle Rottenstein, a lawyer with over two decades of experience in compassionate representation of clients in consumer product injury, mass tort, and class action law suits. For more information, please visit their Web site, or call (888) 9-ROT-LAW.
- Contact Information
- Nava Brahe
- PR Manager
- The Rottenstein Law Group
- Contact via E-mail
This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.
News Release Distribution and Press Release Distribution Services Provided by WebWire.